CO10 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Psoriatic Arthritis
Abstract
Authors
P.J. Mease R.B. Warren P. Nash J.M. Grouin D. Willems V. Taieb J. Eells I. McInnes